Glp-1
- All
- News
-
"Unusual" Side Effect of Ozempic-Like Drugs Challenges Doctors: Research
GLP-1 medications, Ozempic and Wegovy, may disrupt cancer imaging and its diagnosis, new research has revealed.
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
Rising Diabetes In US Kids: Can Mounjaro Be The Answer? New Study Says Yes
A new study reveals Mounjaro may help children as young as 10 manage Type 2 diabetes, significantly reducing blood sugar and weight, with Eli Lilly pushing to expand its use beyond adults.
-
At Wellness Resorts, Ozempic Becomes Part Of The Treatment Menu
A 2024 KFF survey found that about 1 in 8 US adults have used a GLP-1 drug like Ozempic.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
How Rohit Sharma Lost 8 Kg After IPL To Ace BCCI Test. No, He Didn't Use Serena William's-Endorsed GLP-1
In a world obsessed with quick fixes and aesthetic ideals, GLP-1 drugs like Ozempic have emerged as the latest weight-loss trend. But are they a medical marvel or a shortcut with consequences?
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
Serena Williams Reveals She Lost 14 kg Using Weight-Loss Medication: "I Feel Great"
According to Williams, the medication has not only helped her lose weight but also improved her overall health, with noticeable enhancements in her blood sugar levels.
-
Ozempic Vulva: A Side Effect You Didn't Know About
"Ozempic vulva" is a term about how rapid weight loss from GLP-1 medications like Ozempic can affect the vulvas appearance and comfort. Below we discuss causes & tips to manage it.
-
What Happens To Your Body When You Stop Taking Drugs Like Ozempic? Study Explains
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
Considering Weight Loss Drugs? Is Natural Weight Loss More Sustainable And Healthier? Expert Answers
Weight loss drugs help manage blood sugar levels by mimicking two important hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) that regulate insulin secretion and appetite.
-
Ozempic Face? Woman Says It Made Her Look 10 Years Younger
The debate surrounding Ozempic and similar weight loss drugs highlights the benefits and drawbacks of medical weight loss, with some users experiencing positive effects on their appearance and others facing concerns about side effects.
-
Irish Woman Lost Half Her Weight On Ozempic. Here's What Happened After She Stopped
Ashley O'Driscoll, a Dublin woman, lost nearly half her body weight using Ozempic, but faced challenges after stopping the medication, including weight regain and loose skin.
-
"Unusual" Side Effect of Ozempic-Like Drugs Challenges Doctors: Research
GLP-1 medications, Ozempic and Wegovy, may disrupt cancer imaging and its diagnosis, new research has revealed.
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
Rising Diabetes In US Kids: Can Mounjaro Be The Answer? New Study Says Yes
A new study reveals Mounjaro may help children as young as 10 manage Type 2 diabetes, significantly reducing blood sugar and weight, with Eli Lilly pushing to expand its use beyond adults.
-
At Wellness Resorts, Ozempic Becomes Part Of The Treatment Menu
A 2024 KFF survey found that about 1 in 8 US adults have used a GLP-1 drug like Ozempic.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
How Rohit Sharma Lost 8 Kg After IPL To Ace BCCI Test. No, He Didn't Use Serena William's-Endorsed GLP-1
In a world obsessed with quick fixes and aesthetic ideals, GLP-1 drugs like Ozempic have emerged as the latest weight-loss trend. But are they a medical marvel or a shortcut with consequences?
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
Serena Williams Reveals She Lost 14 kg Using Weight-Loss Medication: "I Feel Great"
According to Williams, the medication has not only helped her lose weight but also improved her overall health, with noticeable enhancements in her blood sugar levels.
-
Ozempic Vulva: A Side Effect You Didn't Know About
"Ozempic vulva" is a term about how rapid weight loss from GLP-1 medications like Ozempic can affect the vulvas appearance and comfort. Below we discuss causes & tips to manage it.
-
What Happens To Your Body When You Stop Taking Drugs Like Ozempic? Study Explains
The study found that GLP-1 medications, in particular, showed significant weight regain after treatment discontinuation.
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
Considering Weight Loss Drugs? Is Natural Weight Loss More Sustainable And Healthier? Expert Answers
Weight loss drugs help manage blood sugar levels by mimicking two important hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) that regulate insulin secretion and appetite.
-
Ozempic Face? Woman Says It Made Her Look 10 Years Younger
The debate surrounding Ozempic and similar weight loss drugs highlights the benefits and drawbacks of medical weight loss, with some users experiencing positive effects on their appearance and others facing concerns about side effects.
-
Irish Woman Lost Half Her Weight On Ozempic. Here's What Happened After She Stopped
Ashley O'Driscoll, a Dublin woman, lost nearly half her body weight using Ozempic, but faced challenges after stopping the medication, including weight regain and loose skin.
